News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
41,028 Results
Type
Article (2716)
Company Profile (39)
Press Release (38273)
Section
Business (14990)
Career Advice (84)
Deals (2254)
Drug Delivery (9)
Drug Development (4365)
Employer Resources (10)
FDA (500)
Job Trends (842)
News (21516)
Policy (1161)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (160)
Allergies (4)
Alliances (3658)
ALS (5)
Alzheimer's disease (54)
Antibody-drug conjugate (ADC) (14)
Approvals (501)
Artificial intelligence (10)
Autoimmune disease (2)
Automation (2)
Bankruptcy (12)
Best Places to Work (528)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (29)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (17)
Cancer (138)
Cardiovascular disease (4)
Career advice (69)
Career pathing (1)
CAR-T (14)
Cell therapy (42)
Cervical cancer (2)
Clinical research (3400)
Collaboration (95)
Compensation (44)
COVID-19 (181)
CRISPR (7)
C-suite (27)
Cystic fibrosis (2)
Data (116)
Denatured (3)
Depression (3)
Diabetes (9)
Diagnostics (534)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (13)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4581)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6329)
Executive appointments (90)
FDA (545)
Featured Employer (3)
Funding (79)
Gene editing (14)
Generative AI (1)
Gene therapy (20)
GLP-1 (60)
Government (171)
Healthcare (777)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (15)
Indications (3)
Infectious disease (186)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (11)
Interviews (9)
IPO (1065)
IRA (7)
Job creations (321)
Job search strategy (66)
Kidney cancer (4)
Labor market (3)
Layoffs (37)
Leadership (1)
Legal (234)
Liver cancer (5)
Lung cancer (16)
Lymphoma (3)
Management (4)
Manufacturing (22)
MASH (4)
Medical device (368)
Medtech (368)
Mergers & acquisitions (1252)
Metabolic disorders (32)
Multiple sclerosis (6)
Neurodegenerative disease (8)
Neuropsychiatric disorders (3)
Neuroscience (102)
NextGen: Class of 2025 (376)
Non-profit (173)
Northern California (341)
Now hiring (4)
Obesity (15)
Opinion (19)
Ovarian cancer (10)
Pain (9)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (1)
Patents (20)
Patient recruitment (4)
Peanut (1)
People (5887)
Pharmaceutical (5)
Phase I (1422)
Phase II (1680)
Phase III (970)
Pipeline (80)
Podcasts (4)
Policy (12)
Postmarket research (32)
Preclinical (603)
Press Release (2)
Prostate cancer (5)
Psychedelics (2)
Radiopharmaceuticals (13)
Rare diseases (22)
Real estate (486)
Recruiting (5)
Regulatory (873)
Reports (6)
Research institute (152)
Resumes & cover letters (11)
Schizophrenia (14)
Series A (27)
Series B (5)
Service/supplier (2)
Sickle cell disease (1)
Southern California (369)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (508)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
United States (1706)
Vaccines (29)
Venture capitalists (7)
Webinars (2)
Weight loss (11)
Women's health (1)
Worklife (1)
Date
Last 7 days (68)
Last 30 days (219)
Last 365 days (2684)
2025 (682)
2024 (2754)
2023 (3040)
2022 (3948)
2021 (4312)
2020 (3718)
2019 (2307)
2018 (1730)
2017 (1926)
2016 (1790)
2015 (1994)
2014 (1480)
2013 (1318)
2012 (1539)
2011 (1460)
2010 (1282)
Location
Africa (49)
Alabama (1)
Arizona (14)
Asia (2030)
Australia (342)
California (818)
Canada (133)
China (38)
Colorado (19)
Connecticut (13)
Delaware (3)
Europe (4150)
Florida (45)
Georgia (6)
Idaho (3)
Illinois (15)
India (1)
Indiana (34)
Japan (8)
Kansas (12)
Maryland (25)
Massachusetts (291)
Michigan (8)
Minnesota (15)
Missouri (4)
Nebraska (1)
Nevada (2)
New Hampshire (3)
New Jersey (69)
New York (47)
North Carolina (89)
Northern California (341)
Ohio (26)
Oklahoma (2)
Oregon (4)
Pennsylvania (47)
Rhode Island (2)
South America (53)
South Carolina (1)
Southern California (369)
Tennessee (2)
Texas (67)
Utah (2)
Virginia (6)
Washington D.C. (1)
Washington State (47)
Wisconsin (6)
41,028 Results for "sola biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
SOLA Biosciences Presents Preclinical Proof-of-Concept Data for SOL-257, a Gene Therapy Targeting Misfolded TDP-43 in ALS, at Neuroscience 2023 and ALS One Symposium
As a pioneer in innovative chaperone technology, SOLA Biosciences Inc. will present its compelling preclinical proof-of-concept data for SOL-257, a targeted gene therapy for misfolded TDP-43 in Amyotrophic Lateral Sclerosis, at Neuroscience 2023 in Washington, D.C. on November 15 and the ALS One Symposium on November 17.
November 9, 2023
·
2 min read
Genetown
SOLA Biosciences Shares Preclinical Proof-of-Concept Data for SOL-257, a Gene Therapy Targeting Misfolded TDP-43 in ALS at 22nd Annual NEALS Meeting
SOLA Biosciences, a pioneer in innovative chaperone technology, will present its encouraging preclinical proof-of-concept data for SOL-257, a targeted gene therapy for misfolded TDP-43 in ALS, at the 22nd Annual Northeast ALS Consortium (NEALS) Meeting held in Florida on October 5.
October 3, 2023
·
2 min read
Layoffs
IGM Biosciences Lays Off 73% of Staff, Shrinks Pipeline
Staff cuts will leave IGM Biosciences with 37 employees. The company is also halting development of two bispecific antibody T cell engagers for autoimmune diseases.
January 10, 2025
·
1 min read
·
Angela Gabriel
Press Releases
SolasCure Enrols First Patient in a Next Phase II Clinical Trial to Advance Aurase Wound Gel
March 17, 2025
·
2 min read
Press Releases
Keymed Biosciences Announces Annual Results of 2024
March 27, 2025
·
12 min read
Press Releases
Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors
April 2, 2025
·
5 min read
Press Releases
Marvel Biosciences Announces Private Placement
March 28, 2025
·
6 min read
Press Releases
Aura Biosciences to Participate in Upcoming Investor Conferences
February 26, 2025
·
1 min read
Press Releases
Parse Biosciences Partners with Japanese Distributor, SCRUM Inc.
April 2, 2025
·
2 min read
Press Releases
Arcus Biosciences Announces New Employment Inducement Grants - March 25, 2025
March 26, 2025
·
1 min read
1 of 4,103
Next
